Peter Maple is a clinical scientist and research virologist currently working on virological aspects of demyelinating diseases. Additionally, he is also undertaking clinical and research activity on SARS-CoV-2 infection. His background is in public health microbiology and specialist virology as applied to public health. He spent over 20 years working as a senior clinical scientist for the UK national public health services. Currently, he is based at the Nottingham Centre for Multiple Sclerosis and Neuroinflammation, Department of Neurology, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, UK